BPC-157 Supports Vascular and Neurological Repair One underappreciated hallmark of long COVID is endothelial dysfunction damage to the lining of blood vessels that impairs circulation, oxygenation, and tissue delivery.7 BPC-157 has demonstrated angiogenic (new blood vessel formation) effects in research models, upregulating VEGFR2 and promoting collateral circulation in ischemic tissue.8 This matters for two reasons: Cardiovascular symptoms (breathlessness, reduced exercise tolerance, tachycardia) may partly reflect impaired tissue oxygenation from vascular damage Neurological symptoms (brain fog, cognitive impairment) may similarly reflect reduced cerebral blood flow BPC-157's neuroprotective effects shown across models of traumatic brain injury, dopamine dysregulation, and serotonin syndrome also suggest value in supporting the neurotransmitter disruption many long COVID patients experience.9 BPC-157 Modulates Inflammation Without Immune Suppression This is critical
Cerebrovascular damage may result from the genetic background but also from environmental, vascular, or lifestyle-related risk factors
Lyophilized peptides are generally more stable than peptide solutions, as theyve been freeze-dried, which means the water has been removed
Whether your laboratory is focused on metabolic rate markers, organelle-specific activity, or endocrine signaling, Cagrilintide provides a convenient, high-concentration solution for multi-faceted experimental designs
Instead, BPC-157 appears to upgrade minor vessels to assume the functions of blocked major vessels
